SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-15-000006
Filing Date
2015-11-05
Accepted
2015-11-05 07:54:21
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-9302015x10q3.htm 10-Q 1031328
2 EXHIBIT 31.1 cnce-9302015x10q3ex311.htm EX-31.1 12498
3 EXHIBIT 31.2 cnce-9302015x10q3ex312.htm EX-31.2 12558
4 EXHIBIT 32.1 cnce-9302015x10q3ex321.htm EX-32.1 6782
5 EXHIBIT 32.2 cnce-9302015x10q3ex322.htm EX-32.2 6698
  Complete submission text file 0001367920-15-000006.txt   4484618

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20150930.xml EX-101.INS 768578
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20150930.xsd EX-101.SCH 35264
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20150930_cal.xml EX-101.CAL 65452
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20150930_def.xml EX-101.DEF 154285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20150930_lab.xml EX-101.LAB 465122
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20150930_pre.xml EX-101.PRE 286077
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 151198857
SIC: 2834 Pharmaceutical Preparations